Is Freenome, Inc. Common stock (FRNM) a Buy, Sell, or Hold?
NASDAQ : FRNM
Freenome, Inc. Common stock
$11.15 USD
$0.24 (2.2%)
- Volume
- 548.63K
- Average Volume
- 242.62K
- Market Capitalization
- $90.95M
- P/E Ratio
- Dividend Yield
- %
- Price Target
- Year High
- $14.47
- Year Low
- $9.95
- Day High
- —
- Day Low
- —
- Payout Ratio
- Current Ratio
Company Overview
NASDAQ
Aaron Elliott
Financial - Conglomerates
Financial Services
FRNM
363
US
USD
Liquidity Metrics
Sales & Valuation
-$
Profitability
-$
%
%
%
%
P/E Metrics
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
No financial score data available.
Key Metrics (TTM)
No key metrics data available.
Company Executives
| Name | Title |
|---|---|
| Linh H. Le | Chief Financial Officer |
| Riley Ennis | Co-Founder & Chief Product Officer |
| Julie Tran MSHR | Chief People Officer |
| Sally Howard | Senior Vice President of Regulatory & Quality |
| Cheng-Ho Lin | Chief Scientific Officer |
| Robert Guigley | Chief Commercial Officer |
| Thomas F. Fitzpatrick | Chief Legal Officer |
| Aaron Elliott | CEO & Director |
Poll Results
No votes yet today — be the first to share your view!
About Freenome, Inc. Common stock (NASDAQ:FRNM) Stock
Perceptive Capital Solutions Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Joseph Eric Edelman, Adam Leo Stone, and Michael R. Altman on March 22, 2024 and is headquartered in New York, NY. ...
FDA approves Freenome's blood test for colorectal cancer screening
2026-07-27 09:15:01
The U.S. FDA has approved Freenome's blood-based colorectal cancer screening test for older adults, paving the way for partner Abbott to launch it in the U.S. this fall, the companies said on Monday.
2026-07-27 08:00:00
– Approval expands colorectal cancer screening options for the up to 60 million Americans who are overdue for screening – – Medicare coverage and American Cancer Society guidance support broader access to blood-based colorectal cancer screening – BRISBANE, Calif. and ABBOTT PARK, Ill.
Freenome Debuts as a Publicly Traded Company Focused on Blood-Based Early Cancer Detection
2026-07-20 16:01:00
– Freenome common stock expected to begin trading on the Nasdaq Capital Market under the ticker symbol "FRNM" on July 21, 2026 – – Gross proceeds to Freenome totaled more than $300 million through a PIPE, led by Perceptive Advisors and RA Capital, and funds held by Perceptive Capital Solutions Corp's trust account – – Capital will support Freenome's cancer screening portfolio, AI/ML-enabled multiomics platform and commercial infrastructure - BRISBANE, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- Freenome Holdings, Inc. ("Freenome") (Nasdaq: FRNM), an early cancer detection company developing blood-based screening tests, today announced the closing of its previously announced business combination with Perceptive Capital Solutions Corp. (formerly Nasdaq: PCSC) ("PCSC").
Frequently Asked Questions
-
What is the current Freenome, Inc. Common stock (FRNM) stock price?
-
Freenome, Inc. Common stock(NASDAQ:FRNM) stock price is $11.15 in the last trading session. During the trading session, FRNM stock reached the peak price of $14.47 while $9.95 was the lowest point it dropped to. The percentage change in FRNM stock occurred in the recent session was 2.2% while the dollar amount for the price change in FRNM stock was $0.24.
-
FRNM's industry and sector of operation?
-
The NASDAQ listed FRNM is part of Financial - Conglomerates industry that operates in the broader Financial Services sector.
-
Who are the executives of FRNM?
-
Linh H. Le | Chief Financial Officer
Riley Ennis | Co-Founder & Chief Product Officer
Julie Tran MSHR | Chief People Officer
Sally Howard | Senior Vice President of Regulatory & Quality
Cheng-Ho Lin | Chief Scientific Officer -
How many employees does FRNM have?
-
Number of FRNM employees currently stands at 363. FRNM operates from 3300 Marina Boulevard, Brisbane, CA 94005, US.
-
Link for FRNM official website?
-
Official Website of FRNM is: https://www.freenome.com
-
How do I contact FRNM?
-
FRNM could be contacted at phone #None and can also be accessed through its website. FRNM operates from 3300 Marina Boulevard, Brisbane, CA 94005, US.
-
How many shares of FRNM are traded daily?
-
The average number of FRNM shares traded daily for last 3 months was 242.62K.
-
What is the market cap of FRNM currently?
-
The market value of FRNM currently stands at $90.95M with its latest stock price at $11.15